
Sanofi SNY
$ 47.6
-0.61%
Annual report 2025
added 04-04-2026
Sanofi DSO Ratio 2011-2026 | SNY
Annual DSO Ratio Sanofi
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | 95.2 | 92.7 | 96.4 | 97 | 97.5 | 83.7 |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 97.5 | 83.7 | 93.8 |
DSO Ratio of other stocks in the Biotechnology industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
I-Mab
IMAB
|
271 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 | - | - | $ 40.3 B | ||
|
Midatech Pharma plc
MTP
|
204 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K | - | -1.52 % | $ 24.7 M | ||
|
Acorda Therapeutics
ACOR
|
48.3 | - | -24.86 % | $ 820 K | ||
|
Advaxis
ADXS
|
88.1 | - | -9.65 % | $ 45.9 M | ||
|
Adverum Biotechnologies
ADVM
|
222 | - | - | $ 86.2 M | ||
|
Aeterna Zentaris
AEZS
|
146 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
186 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
216 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.114 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | ||
|
CureVac N.V.
CVAC
|
13.6 | - | - | $ 867 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
58.1 | $ 330.34 | 3.6 % | $ 43.3 B | ||
|
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | ||
|
Evogene Ltd.
EVGN
|
30 | $ 0.79 | 1.22 % | $ 27.9 M | ||
|
Фармсинтез
LIFE
|
209 | - | - | - | ||
|
Aptorum Group Limited
APM
|
20.6 | $ 0.89 | -4.33 % | $ 4.85 M | ||
|
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | ||
|
Teligent, Inc.
TLGT
|
90.7 | - | -13.85 % | $ 16.1 M | ||
|
AbbVie
ABBV
|
258 | $ 206.69 | -1.01 % | $ 366 B | ||
|
Aquestive Therapeutics
AQST
|
103 | $ 4.09 | -0.97 % | $ 437 M | ||
|
Aravive
ARAV
|
16.8 | - | -13.39 % | $ 1.45 M | ||
|
Viela Bio, Inc.
VIE
|
169 | - | - | $ 2.91 B | ||
|
AbCellera Biologics
ABCL
|
173 | $ 3.39 | -3.69 % | $ 1.01 B | ||
|
Arcturus Therapeutics Holdings
ARCT
|
21.2 | $ 8.22 | 2.37 % | $ 225 M | ||
|
Ardelyx
ARDX
|
58 | $ 5.97 | 0.51 % | $ 1.44 B | ||
|
Genmab A/S
GMAB
|
97.9 | $ 27.75 | 0.91 % | $ 17.6 B | ||
|
Akebia Therapeutics
AKBA
|
62.9 | $ 1.32 | -4.35 % | $ 339 M |